Effectiveness of non-pharmacological COPD management on health-related quality of life - a systematic review

References

• Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The top 10 causes of death; 2018 [updated 2018 May 24; cited 2019 Oct]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
   Google Scholar
• Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221.
   PubMedGoogle Scholar
• GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706.
   PubMed Web of Science ®Google Scholar
• Guarascio AJ, Ray SM, Finch CK, et al. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicon Econ Outcomes Res. 2013;5:235–245.
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD; 2019 [cited 2019 Dec]. Available from: http://goldcopd.org
   Google Scholar
• Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach, WHO, Switzerland. 2007.
   Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946.
   PubMed Web of Science ®Google Scholar
• Jones PW. Health status and the spiral of decline. Copd. 2009;6(1):59–63.
   PubMedGoogle Scholar
• Fletcher C. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). London, British medical journal. 1960.
   Google Scholar
• Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95–99.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852.
   PubMed Web of Science ®Google Scholar
• Spencer S, Jones PW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. 2003;58(7):589–593.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555.
   PubMed Web of Science ®Google Scholar
• Strong K, Mathers C, Leeder S, et al. Preventing chronic diseases: how many lives can we save? Lancet. 2005;366(9496):1578–1582.
   PubMed Web of Science ®Google Scholar
• Montuschi P. Pharmacological treatment of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2006;1(4):409–423.
   PubMedGoogle Scholar
• Pauwels R, Buist A, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(5):1256–1276.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269, w264.
   PubMed Web of Science ®Google Scholar
• Lefebvre C, Manheimer E, Glanville J. Chapter 6: searching for studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions 5.1 [updated March 2011]. London: The Cochrane Collaboration; 2011:99 - 101.
   Google Scholar
• Jones PW, Quirk FH, Baveystock CM. The St George’s respiratory questionnaire. Respir Med. 1991;85(Suppl B):25–31; discussion 33–27.
   Google Scholar
• Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327.
   PubMed Web of Science ®Google Scholar
• Lee BY, Lee S, Lee JS, et al. Validity and reliability of CAT and Dyspnea-12 in bronchiectasis and tuberculous destroyed lung. Tuberc Respir Dis (Seoul). 2012;72(6):467–474.
   PubMedGoogle Scholar
• Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773–778.
   PubMed Web of Science ®Google Scholar
• Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration: London. 2011.
   Google Scholar
• Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002;19(3):398–404.
   PubMed Web of Science ®Google Scholar
• Jones PW. St. George’s respiratory questionnaire: MCID. Copd. 2005;2(1):75–79.
   PubMedGoogle Scholar
• Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clin Trials. 1989;10(4):407–415.
   PubMedGoogle Scholar
• van der Molen T, Willemse BWM, Schokker S, et al. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:13.
   PubMedGoogle Scholar
• Kocks JW, Tuinenga MG, Uil SM, et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7:62.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654.
   PubMed Web of Science ®Google Scholar
• Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203.
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Nolan CM, Longworth L, Lord J, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500.
   PubMed Web of Science ®Google Scholar
• Zanini A, Aiello M, Adamo D, et al. Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respir Care. 2015;60(1):88–95.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:1–9.
   Google Scholar
• The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan); 2014.
   Google Scholar
• Yamaguti WP, Claudino RC, Neto AP, et al. Diaphragmatic breathing training program improves abdominal motion during natural breathing in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Arch Phys Med Rehabil. 2012;93(4):571–577.
   PubMed Web of Science ®Google Scholar
• Altenburg WA, Ten Hacken NH, Bossenbroek L, et al. Short- and long-term effects of a physical activity counselling programme in COPD: a randomized controlled trial. Respir Med. 2015;109(1):112–121.
   PubMed Web of Science ®Google Scholar
• Borges RC, Carvalho CR. Impact of resistance training in chronic obstructive pulmonary disease patients during periods of acute exacerbation. Arch Phys Med Rehabil. 2014;95(9):1638–1645.
   PubMed Web of Science ®Google Scholar
• Hospes G, Bossenbroek L, Ten Hacken NH, et al. Enhancement of daily physical activity increases physical fitness of outclinic COPD patients: results of an exercise counseling program. Patient Educ Couns. 2009;75(2):274–278.
   PubMed Web of Science ®Google Scholar
• Barakat S, Michele G, George P, et al. Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(1):155–162.
   PubMedGoogle Scholar
• Daabis R, Hassan M, Zidan M. Endurance and strength training in pulmonary rehabilitation for COPD patients. Egypt J Chest Dis Tuberculosis. 2017;66(2):231–236.
   Web of Science ®Google Scholar
• Elci A, Borekci S, Ovayolu N, et al. The efficacy and applicability of a pulmonary rehabilitation programme for patients with COPD in a secondary-care community hospital. Respirology. 2008;13(5):703–707.
   PubMed Web of Science ®Google Scholar
• He M, Yu S, Wang L, et al. Efficiency and safety of pulmonary rehabilitation in acute exacerbation of chronic obstructive pulmonary disease. Med Sci Monit. 2015;21:806–812.
   PubMed Web of Science ®Google Scholar
• Ko FW, Dai DL, Ngai J, et al. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD. Respirology. 2011;16(4):617–624.
   PubMed Web of Science ®Google Scholar
• Gu W-L, Liang Z-Y, Zhu C-B, et al. Clinical outcome of a novel breathing training maneuver in stable COPD patients. Int J Clin Exp Med. 2018;11(9):9802–9810.
   Web of Science ®Google Scholar
• Lin WC, Yuan SC, Chien JY, et al. The effects of respiratory training for chronic obstructive pulmonary disease patients: a randomised clinical trial. J Clin Nurs. 2012;21(19–20):2870–2878.
   PubMed Web of Science ®Google Scholar
• Majewska-Pulsakowska M, Wytrychowski K, Rozek-Piechura K. The role of inspiratory muscle training in the process of rehabilitation of patients with chronic obstructive pulmonary disease. Adv Exp Med Biol. 2016;885:47–51.
   PubMed Web of Science ®Google Scholar
• Gottlieb V, Lyngso AM, Nybo B, et al. Pulmonary rehabilitation for moderate COPD (GOLD 2)–does it have an effect? Copd. 2011;8(5):380–386.
   PubMedGoogle Scholar
• Seymour JM, Moore L, Jolley CJ, et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax. 2010;65(5):423–428.
   PubMed Web of Science ®Google Scholar
• Wootton SL, Ng LW, McKeough ZJ, et al. Ground-based walking training improves quality of life and exercise capacity in COPD. Eur Respir J. 2014;44(4):885–894.
   PubMed Web of Science ®Google Scholar
• ATS. Pulmonary rehabilitation-1999. American Thoracic Society. Am J Respir Crit Care Med. 1999;159(5Pt 1):1666–1682.
   PubMedGoogle Scholar
• Bourbeau J. Activities of life: the COPD patient. Copd. 2009;6(3):192–200.
   PubMedGoogle Scholar
• Marchetti N, Criner GJ, Albert RK. Preventing acute exacerbations and hospital admissions in COPD. Chest. 2013;143(5):1444–1454.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422.
   PubMed Web of Science ®Google Scholar
• Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med. 2013;1(1):43–50.
   PubMed Web of Science ®Google Scholar
• Jones GL. Quality of life changes over time in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2016;22(2):125–129.
   PubMed Web of Science ®Google Scholar
• Brooks D, Krip B, Mangovski-Alzamora S, et al. The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease. Eur Respir J. 2002;20(1):20–29.
   PubMed Web of Science ®Google Scholar
• Foglio K, Bianchi L, Bruletti G, et al. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J. 1999;13(1):125–132.
   PubMed Web of Science ®Google Scholar
• Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5Suppl):4s–42s.
   PubMed Web of Science ®Google Scholar
• Steele BG, Belza B, Cain KC, et al. A randomized clinical trial of an activity and exercise adherence intervention in chronic pulmonary disease. Arch Phys Med Rehabil. 2008;89(3):404–412.
   PubMed Web of Science ®Google Scholar
• Jones R, Østrem A. Optimising pharmacological maintenance treatment for COPD in primary care. Primary Care Respir J. 2011;20(1):33–45.
   PubMedGoogle Scholar
• Miravitlles M, D’Urzo A, Singh D, et al. Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review. Respir Res. 2016;17(1):112.
   PubMed Web of Science ®Google Scholar
• Clini E, Venturelli E, Crisafulli E. Rehabilitation in COPD patients admitted for exacerbation. Pneumonologia i alergologia polska. 2011;79(2):116–120.
   PubMedGoogle Scholar
• Eaton T, Young P, Fergusson W, et al. Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study. Respirology. 2009;14(2):230–238.
   PubMed Web of Science ®Google Scholar
• Tang CY, Blackstock FC, Clarence M, et al. Early rehabilitation exercise program for inpatients during an acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2012;32(3):163–169.
   PubMed Web of Science ®Google Scholar
• Torres-Sanchez I, Valenza MC, Cabrera-Martos I, et al. Effects of an exercise intervention in frail older patients with chronic obstructive pulmonary disease hospitalized due to an exacerbation: a randomized controlled trial. Copd. 2017;14(1):37–42.
   PubMedGoogle Scholar
• Franssen FM, Alter P, Bar N, et al. Personalized medicine for patients with COPD: where are we? Int J Chron Obstruct Pulmon Dis. 2019;14:1465–1484.
   PubMed Web of Science ®Google Scholar
• Andrianopoulos V, Klijn P, Franssen FM, et al. Exercise training in pulmonary rehabilitation. Clin Chest Med. 2014;35(2):313–322.
   PubMed Web of Science ®Google Scholar
• Spruit MA, Wouters EFM. Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases. Respirology. 2019;24(9):838–843.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008;63(6):487–492.
   PubMed Web of Science ®Google Scholar
• Grosbois JM, Heluain-Robiquet J, Machuron F, et al. Influence of socioeconomic deprivation on short- and long-term outcomes of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:2441–2449.
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre. National institute for health and clinical excellence: guidance. In: Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: Royal College of Physicians (UK) National Clinical Guideline Centre - Acute and Chronic Conditions; 2010.
   Google Scholar
• Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–1413.
   PubMed Web of Science ®Google Scholar
• Spruit M, Singh S, Garvey C, et al. An Official American Thoracic Society/European Respiratory Society Statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.
   PubMed Web of Science ®Google Scholar
• McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:Cd003793.DOI: 10.1002/14651858.CD003793.pub3.
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Goldstein R, Lasserson TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:Cd003793.
   PubMed Web of Science ®Google Scholar
• Vieira DS, Maltais F, Bourbeau J. Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2010;16(2):134–143.
   PubMed Web of Science ®Google Scholar
• Maher CG, Sherrington C, Herbert RD, et al. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83(8):713–721.
   PubMed Web of Science ®Google Scholar
• Pickard AS, Yang Y, Lee TA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011;9:26.
   PubMed Web of Science ®Google Scholar
• Westwood M, Bourbeau J, Jones PW, et al. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res. 2011;12:40.
   PubMed Web of Science ®Google Scholar
• Wacker ME, Jorres RA, Karch A, et al. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies. Respir Res. 2016;17(1):81.
   PubMed Web of Science ®Google Scholar
• Vale F, Reardon JZ, ZuWallack RL. The long-term benefits of outpatient pulmonary rehabilitation on exercise endurance and quality of life. Chest. 1993;103(1):42–45.
   PubMed Web of Science ®Google Scholar